News & Events

Catch Demeetra at PEGS Boston 2025 May 12-16, 2025 Hynes Convention Center | Boston, MA We’re bringing our latest innovations in gene editing and cell line engineering to PEGS Boston 2025-and we’d love to connect. Stop by Booth #806 to meet our Business Development Managers, Koy Saephan and Christian Cummings, and learn how Demeetra is…55

Demetra Heads to Hamburg for BioProcess International Europe 2025 May 12-15, 2025Congress Center Hamburg | Hamburg, Germany We’re heading to Hamburg! Demeetra will be on site at BioProcess International Europe 2025, one of the most influential gatherings for bioprocessing leaders, innovators, and scientists driving the future of biologics. Our CEO, Jack Crawford, will be in…55

Meet Demeetra at SynBioBeta 2025 May 5-8, 2025 San Jose Convention Center – San Jose, CA Demeetra is heading to SynBioBeta 2025, the premier Global Synthetic Biology Conference, taking place May 5-8 in San Jose, California. Our Business Development Manager, Koy Saephan, will be attending and looks forward to connecting with leaders and innovators advancing…55

Meet Demeetra at Festival of Biologics USA 2025 April 23-25, 2025San Diego Convention Center – San Diego, CA Demeetra is heading to San Diego for Festival of Biologics USA 2025! Join us April 23-25 at one of the leading events connecting biologics professionals across discovery, development, and manufacturing. Our Business Development Manager, Koy Saephan, will…55

CLOVER Gene Editing Technology Licensed to Hudson River Biotechnology LEXINGTON, KY – Demeetra AgBio, a pioneer in precision gene editing technologies for commercially applicable systems, is proud to announce that Hudson River Biotechnology has officially in-licensed our cutting-edge CLOVER genome editing tool. This strategic partnership marks a significant milestone in advancing agricultural biotechnology and sustainable crop production. The…55

Demeetra to Present Preclinical Data on Investigational Cannabinoid Derivatives at the 2025 Crohn’s and Colitis Congress Novel non-natural small molecules DM350-P and DM300 outperform natural cannabinoids, steroid and immune suppressant positive controls in a mouse Colitis and rat Crohn’s model. The data presented will highlight the significant impact of medicinal chemistry on cannabinoid pharmacology, demonstrating…55

Demeetra Cas-CLOVER Research Selected as a MDPI Journal Editor’s Choice Article Lexington, KY and Bloomington, IN: A pioneering study, authored by scientists from Demeetra and Indiana University, has been selected for the MDPI Journals Editor’s Choice Articles, highlighting the impact of advanced gene editing in synthetic biology to produce biopesticides. Published in Fermentation in 2023, Generation…55

Demeetra Was Proud to Present at BioProcess International West 2024 Meet our team for an introduction to our CRISPR alternative, Cas-CLOVER™. You can also catch us at our poster “piggyBac Transposase and Cas-CLOVER Targeted Nuclease Enable Rapid Discovery of Novel Hot Spots in HEK293 Suspension Cells“ March 11-14, 2024Town and Country Resort, San Diego, California…55

Proud to Attend 23rd Annual PepTalk PepTalk provides a comprehensive program and innovative solutions in antibody development, biologics characterization, and expression platforms. January 16-19, 2024 Hilton San Diego Bayfront – San Diego, CA Conference Info Meet with Demeetra! Gianguido Coffa will be attending PepTalk on January 16-17. While attending, he would love to meet in…55